This article in the New York Times describes the innovations and changes that clinical trials have made during the pandemic. At the start of the pandemic, nearly 6,000 of the clinical trials registered on clinicaltrials.gov were stopped. For clinical trials that weren’t stopped, researchers re-designed their clinical trials to include virtual monitoring and remote visits… Continue reading Clinical Trials Innovations during COVID-19
Patients that suffer from one (or more) of the nearly 7,000 rare diseases currently recognized have to fight for their diagnosis, treatments, and communication from medical providers. There are between 25-30 million people in America and 30 million in Europe suffering from rare diseases. For these patients being curious about their diagnosis and symptoms is… Continue reading Rare Disease Awareness
Clinical trials have a diversity problem – despite making up 40% of the US population, people of color sometimes represent only about 10-20% of clinical trial enrollments. This can result in misleading conclusions about how therapies will ultimately perform across different demographics. Black communities, in particular, have had to endure mistreatment in clinical trials historically,… Continue reading Racial Diversity in Clinical Trials
The past year has been a challenging one on many levels. A global pandemic has brought on issues of fear, financial concerns and the unknown. Many may feel a sense of apathy and difficulties finding a sense of purpose. One way to consider trying to find a ray of hope and a glimmer of happiness… Continue reading Getting Through Giving
By Kartik Ramkumar, Patient Success Manager at Leapcure In some of my patient conversations, what stands out the most is the stress and frustration in their voice. They share their symptoms (often chronic or difficult) and express their frustration with misdiagnoses and the lack of available answers to why they are experiencing certain symptoms. Sometimes,… Continue reading Addressing the Knowledge Gap among Rare Disease Patients
If you work in clinical research, you know that one of the most difficult parts is enrolling a sufficient number of patients into a clinical trial. Beyond finding patients that are diagnosed with a potentially rare condition, there are inclusion and exclusion criteria that can narrow the field of eligible patients much further – sometimes… Continue reading Leapcure’s Three Pillars of Clinical Trial Recruitment
Leapcure is an organization whose work can cut years off research timelines, getting important treatments to patients who need them faster. In the past 12 months, we have seen the speed and efficiency with which the research world has pulled together to develop, approve and distribute vaccines and treatments globally. Considering that the average clinical… Continue reading The Lasting Impact of COVID-19 on the Research World
Leapcure was started in 2015 because Clinical Trials were designed without anticipating behaviors. Patient advocacy groups were too often on the outside of the study planning process. Researcher burden was frequently an afterthought. The patient experience came last. When we accompany our CRO clients in bid defenses, we still go in hoping for the last… Continue reading Our challenges and opportunities – looking back from 1/20/21 (anagram day!)
As 2020 comes to a close we reflect back on what was a difficult year for everyone. The world of clinical trials received a spotlight like never before, but also presents its own unique challenges. The good news is that patients are still ready and willing to join clinical trials despite their fears of contracting… Continue reading 3 Lessons from Patient Recruitment during COVID
I am deeply saddened to share the passing of Spencer Sims. Spencer was one of Leapcure’s original co-founders. He helped us create Leapcure from nothing and played a key role for us when we went from just an idea to a company. Spencer was a loving, caring, passionate person. He was a challenger. He encouraged… Continue reading Passing of Spencer Sims
